Skip to main content
. Author manuscript; available in PMC: 2015 Jun 14.
Published in final edited form as: Ann Intern Med. 2013 Mar 5;158(5 0 1):338–346. doi: 10.7326/0003-4819-158-5-201303050-00007

Appendix Table 1. Characteristics of the 14 included studies evaluating the association between atrial fibrillation and cognitive impairment in patients with or without history of stroke.

Author Year Design & Settings (Comparison
Groups)
N Female,% Age, Mean (SD) CVA
Exclusion
Country
Ott
1997 (28)
Cross-sectional community cohort
(cognitive impairment vs. no cognitive
impairment, and dementia vs. no
cognitive impairment )
6584 59.2 69.2 (9.1) No* The
Netherlands
Cacciatore
1998 (29)
Cross-sectional community survey
(MMSE <24 vs. MMSE ≥24)
1075 55.3 73.9 (6.2) Yes Italy
Tilivis
2004 (33)
Prospective cohort with up to 10 yrs of
follow-up (change in cognitive function
over time, in patients with AF vs. no AF)
650 73.61 Age at entry
75 (37%)
80 (32.7%)
85 (30.2% )
No Finland
Elias
2006 (13)
Prospective cohort of the Framingham
Offspring Heart Study with assessment of
cognitive function an average of 8 mos
after the AF surveillance period (chronic
or paroxysmal AF vs. no AF followed for
development of dementia)
1011 0 No AF:60.5 (9.4)
AF: 68.1 (7.0)
Yes United States
Jozwiak 2006
(30)
Cross-sectional study (4 comparison
groups : AF alone; AF with FNDs; FNDs
alone; neither AF nor FNDs)
2314 65 76§ (71- 81) Yes Poland
Debette 2007
(31)
Cross-sectional study of HF patients with
LVEF ≤45% (MMSE <24 vs. MMSE
≥24)
83 30.1 62§ (17-98) ** No France
Forti
2007 (34)
Prospective cohort with 3 and 4 yrs of
follow-up for patients with MCI and
normal cognitive function, respectively
(evaluating conversion to dementia,
comparing converters vs. nonconverters)
Normal:4
31 MCI:
180
Normal: 63
MCI: 51
Normal: 75.2
(9.0)
MCI: 75.7 (8.3)
No Italy
Bilato
2009 (32)
Cross-sectional assessment of
participants in the Progetto Veneto
Anziani (Pro.V.A.) study (comparing
cognitive impairment in patients with AF
vs. no AF)
1,576 61.5 Men: 77 (8)
Women: 76 (7)
No Italy
Marengoni
2009 (14)
Prospective cohort with 6 yrs of follow-
up (AF vs. no AF )
685 75.6 †† 83.6 (4.1) †† Yes‡‡ Sweden
Peters
2009 (16)
Prospective cohort of hypertensive
elderly with mean follow-up of 2 yrs
(development of dementia in patients
with AF vs. no AF )
3336 60.4 >=80 No United
Kingdom
Bunch
2010 (11)
Prospective cohort with mean follow-up
of 5 yrs (development of dementia in
patients with AF vs. no AF )
37,025 39.9 60.6 (17.9) No United States
Dublin
2011 (12)
Prospective cohort of community-
dwelling adults with mean follow-up of
6.8 yrs (development of dementia in AF
vs. No AF)
3,045 60 75.3 (6.18) †† Yes United States
Li
2011 (35)
Prospective cohort of patients with MCI
with mean follow-up of 5 yrs (evaluating
conversion to AD )
837§§ Convertors:
62.8
Non-
convertors:
54.5
66.5 (7.12) †† No China
Marzona
2012 (36)
Prospective cohort (post-hoc analysis of
two randomized controlled trials) with
median follow-up of 56 mos (AF vs. no
AF )
31,506 29.7 66.5 (7.2) No* 40 countries

Studies are ordered based on the publication year.

*

Excluded patients with stroke history in a secondary analysis.

Only 629 were included in the analysis.

Including patients in all the four comparison groups.

§

Median age.

Inter-quartile range.

Two comparison groups for this meta-analysis were: AF alone vs. neither AF nor focal neurologic deficits.

**

Age range.

††

Per contact with the author.

‡‡

Only excluded patients with history of stroke at baseline and did not exclude incident stroke cases during the follow up.

§§

638 completed the follow-up.

SD: Standard Deviation; CVA: Cerebrovascular Accidents; MMSE: Mini-mental State Examination; AF: Atrial fibrillation; FND: Focal Neurologic Deficit; HF: Heart Failure; LVEF: Left Ventricular Ejection Fraction; MCI: Mild Cognitive Impairment; AD: Alzheimer’s disease